ReSCiD Project
Revolutionising medical device sustainability
Eligibility
United Kingdom
Every year, the healthcare industry produces approximately 2.5 billion disposable injection devices, contributing to a total Greenhouse Gas (GHG) equivalent of 750,000 tCO₂e . Currently, there are no viable alternatives to single-use injectors — until now.
ReSCiD (Remanufacturing for a Sustainable Future in Combination Injection Devices) is collaboration pioneering a circular economy approach, introducing remanufacturable devices to reduce emissions by at least 95% while maintaining safety, quality, and performance.
The pharmaceutical and medical device industries rely heavily on disposable plastic-based injection devices, creating an urgent sustainability challenge. Existing solutions focus on recycling, but true impact comes from remanufacturing and reuse.
ReSCiD aims to transform the industry by:
• Developing innovative processes for the return, disassembly, refurbishment, and reintegration of used devices.
• Establishing a Good Manufacturing Practice (GMP)-compliant decontamination and supply chain framework.
• Reducing reliance on raw materials, lowering production energy demands, and minimising waste.
By rethinking device life cycles, we are creating a practical and scalable alternative to single-use injectors.
Creating a remanufacturing model requires expertise across multiple disciplines. ReSCiD is bringing together key industry players to establish a comprehensive ecosystem that ensures sustainability, safety, and efficiency.
We are seeking partners with knowledge in:
• Pharmaceutical drug distribution
• Primary container and autoinjector design
• Clinical applications and healthcare partnerships
• Sustainable material innovation (e.g., bio-based plastics, polymers)
• Reverse logistics for collection and sorting
• Cleaning, decontamination, and regulatory compliance
• Component tracking and lifecycle analytics
By leveraging expertise in these areas, ReSCiD will redefine the standard for medical device sustainability.
ReSCiD is a joint initiative led by Owen Mumford in collaboration with CPI. This project is funded by Innovate UK, supporting the drive towards net-zero healthcare solutions.
We are shaping the future of sustainable medical devices. Whether you are a pharmaceutical company, medical device manufacturer, healthcare provider, or sustainability expert, your expertise can help make this vision a reality.
We are building the consortium during the first half of 2025 and will be looking to start the project in 2025.
To find out more about how we can work together, please enter your details below.